Effect of combining viscous fibre with lovastatin on serum lipids in normal human subjects

International Journal of Clinical Practice

Volumn 61, Issue 11, 2007, Pages 1812-1818

  Agrawal, A R ^a,c   Tandon, M ^b   Sharma, P L ^a  

^a HAMDARD UNIVERSITY   (India)

^b RANBAXY RESEARCH LABORATORIES   (India)

^c House No 467   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ISPAGULA; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; STATINE DERIVATIVE; TRIACYLGLYCEROL;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY FIBER; DRUG EFFECT; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; HUMAN EXPERIMENT; LIPID ANALYSIS; LIPID BLOOD LEVEL; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; ANTICHOLESTEREMIC AGENTS; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DRUG THERAPY, COMBINATION; HUMANS; HYPERCHOLESTEROLEMIA; LOVASTATIN; MALE; MIDDLE AGED; PSYLLIUM; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 35348871890     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2007.01512.x     Document Type: Article

References (25)

1. Evans M, Roberts A, Davies S, Rees A. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments. Drugs 2004 64 : 1181 96.
2. Ito MK, Cheung RJ, Gupta EK et al. Key articles, guidelines, and consensus papers relative to the treatment of dyslipidemias - 2005. Pharmacotherapy 2006 26 : 939 1010.
3. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 2001 104 : 2746 53.
4. Third Report of the NCEP Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report, September 2002.
5. Tang JL, Armitage JM, Lancaster T, Silagy CA, Fowler GH, Neil HA. Systematic review of dietary intervention trials to lower blood total cholesterol in free-living subjects. BMJ 1998 316 : 1213 20.
6. Aquilani R, Tramarin R, Pedretti RF et al. Despite good compliance, very low fat diet alone does not achieve recommended cholesterol goals in outpatients with coronary heart disease. Eur Heart J 1999 20 : 1020 9.
7. Jula A, Marniemi J, Huupponen R, Virtanen A, Rastas M, Ronnemaa T. Effects of diet and simvastatin on serum lipids, insulin, and antioxidants in hypercholesterolemic men: a randomized controlled trial. JAMA 2002 287 : 598 605.
8. Jenkins DJ, Kendall CW, Marchie A et al. The effect of combining plant sterols, soy protein, viscous fibers, and almonds in treating hypercholesterolemia. Metabolism 2003 52 : 1478 83.
9. Richter WO. Interaction between fibre and lovastatin. Lancet 1991 338 : 706.
10. Enas EA, Mehta J. Malignant coronary artery disease in young Asian Indians: thoughts on pathogenesis, prevention, and therapy. Coronary Artery Disease in Asian Indians (CADI) Study. Clin Cardiol 1995 18 : 131 5.
11. Rissam HS, Kishore S, Trehan N. Coronary artery disease in young Indians - the missing link. J Indian Acad Clin Med 2001 2 : 128 32.
12. Goyal A, Yusuf S. The burden of cardiovascular disease in the Indian subcontinent. Indian J Med Res 2006 124 : 235 44.
13. Davidson MH, Dugan LD, Burns JH, Bova J, Story K, Drennan KB. The hypocholesterolemic effects of beta-glucan in oatmeal and oat bran. A dose-controlled study. JAMA 1991 265 : 1833 9.
14. Ramsay LE, Yeo WW, Jackson PR. Dietary reduction of serum cholesterol concentration: time to think again. BMJ 1991 303 : 953 7.
15. Smith GD, Ibrahin S. Commentary: Dietary change, cholesterol reduction, and the public health - what does meta-analysis add? BMJ 1998 316 : 1220.
16. Sprecher DL, Harris BV, Goldberg AC et al. Efficacy of psyllium in reducing serum cholesterol levels in hypercholesterolemic patients on high- or low-fat diets. Ann Intern Med 1993 119 : 545 54.
17. Tavintharan S, Lim SC, Sum CF. Patients with low levels of high-density lipoprotein cholesterol: to treat or not to treat? Singapore Med J 2005 46 : 519 28.
18. Rupa N. Meet psyllium: a fiber product with potential cardioprotective effects. Nutr Noteworthy 2005 7 : Article 3.
19. Wolever TM, Jenkins DJ, Mueller S et al. Method of administration influences the serum cholesterol-lowering effect of psyllium. Am J Clin Nutr 1994 59 : 1055 9.
20. Glore SR, Van Treeck D, Knehans AW, Guild M. Soluble fiber and serum lipids: a literature review. J Am Diet Assoc 1994 94 : 425 36.
21. Thompson GR, O'Neill F, Seed M. Why some patients respond poorly to statins and how this might be remedied. Eur Heart J 2002 23 : 200 6.
22. Anderson JW. Diet first, then medication for hypercholesterolemia. JAMA 2003 290 : 531 3.
23. Moreyra AE, Wilson AC, Koraym A. Effect of combining psyllium fiber with simvastatin in lowering cholesterol. Arch Intern Med 2005 165 : 1161 6.
24. Anderson JW, Allgood LD, Lawrence A et al. Cholesterol-lowering effects of psyllium intake adjunctive to diet therapy in men and women with hypercholesterolemia: meta-analysis of 8 controlled trials. Am J Clin Nutr 2000 71 : 472 9.
25. Anderson JW, Davidson MH, Blonde L et al. Long-term cholesterol-lowering effects of psyllium as an adjunct to diet therapy in the treatment of hypercholesterolemia. Am J Clin Nutr 2000 71 : 1433 8.